XERS - Xeris Pharmaceuticals EPS misses by $0.14 misses on revenue August, 05 2021 07:08 AM Xeris Pharmaceuticals Inc. Xeris Pharmaceuticals (NASDAQ:XERS): Q2 GAAP EPS of -$0.41 misses by $0.14. Revenue of $8.84M (+346.5% Y/Y) misses by $4.95M. Press Release For further details see: Xeris Pharmaceuticals EPS misses by $0.14, misses on revenue